Tax-withholding stock sale by Twist Bioscience (TWST) accounting chief
Rhea-AI Filing Summary
Twist Bioscience Corp Chief Accounting Officer Robert F. Werner reported a small mandated stock sale to cover taxes. On the transaction date, he sold 800 shares of common stock in an open-market transaction at an average price of $62.484 per share.
According to the footnote, this sale was required to satisfy tax withholding obligations tied to the vesting of Restricted Stock Units under the company’s equity incentive plans and was not a discretionary trade. After this sale, Werner directly holds 48,186 shares of Twist Bioscience common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 800 shares
Net Sell
1 txn
Insider
WERNER ROBERT F.
Role
Chief Accounting Officer
Sold
800 shs ($50K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 800 | $62.484 | $50K |
Holdings After Transaction:
Common Stock — 48,186 shares (Direct)
Footnotes (1)
- F1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Key Figures
Shares sold: 800 shares
Average sale price: $62.484 per share
Shares held after transaction: 48,186 shares
3 metrics
Shares sold
800 shares
Open-market sale on reported transaction date
Average sale price
$62.484 per share
Price for the 800-share sale
Shares held after transaction
48,186 shares
Direct ownership after the sale
Key Terms
Restricted Stock Units, tax withholding obligations, sell to cover, equity incentive plans
4 terms
Restricted Stock Units financial
"in connection with the vesting of Restricted Stock Units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"shares required to be sold ... to cover tax withholding obligations"
sell to cover financial
"funded by a "sell to cover" transaction"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
equity incentive plans financial
"mandated by the Issuer's election under its equity incentive plans"
Equity incentive plans are company programs that pay employees, executives, or directors with company stock, stock options, or share units instead of or in addition to cash, aiming to align their interests with shareholders—like giving team members a stake in the house they help build. For investors this matters because such plans can motivate better company performance but also dilute existing ownership and increase reported compensation costs, so they affect future earnings, voting power, and share value.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Twist Bioscience (TWST) disclose for Robert F. Werner?
Twist Bioscience disclosed that Chief Accounting Officer Robert F. Werner sold 800 shares of common stock. The sale was reported as an open-market transaction and was tied to tax withholding for Restricted Stock Unit vesting under the company’s equity incentive plans.
Was the Twist Bioscience (TWST) insider sale by the CAO discretionary?
No, the filing states the sale was not discretionary. The footnote clarifies it was mandated by Twist Bioscience’s equity incentive plans as a “sell to cover” transaction to fund tax withholding arising from Restricted Stock Unit vesting.